Revise HIPAA: Health researchers

A rule meant to protect the privacy of medical patients impedes critical health research by limiting access to stored tissue and genetic datasets and by hampering research participant recruitment, according to an Association of Academic Health Centers (AAHC) linkurl:report;http://www.aahcdc.org/policy/reddot/AAHC_HIPAA_Creating_Barriers.pdf released yesterday (Jun 16). This sentiment echoes linkurl:concerns;http://www.the-scientist.com/blog/display/53866/ previously voiced by US epidemiologists,

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A rule meant to protect the privacy of medical patients impedes critical health research by limiting access to stored tissue and genetic datasets and by hampering research participant recruitment, according to an Association of Academic Health Centers (AAHC) linkurl:report;http://www.aahcdc.org/policy/reddot/AAHC_HIPAA_Creating_Barriers.pdf released yesterday (Jun 16). This sentiment echoes linkurl:concerns;http://www.the-scientist.com/blog/display/53866/ previously voiced by US epidemiologists, who linkurl:said;http://jama.ama-assn.org/cgi/reprint/298/18/2164.pdf the Privacy Rule of the Health Insurance Portability and Accountability Act (HIPAA) has made their research more difficult to conduct since its enactment in 2003. The AAHC convened focus groups at several US academic medical centers, and researchers and administrators there said that HIPAA increased administrative burden with additional paperwork, created confusion over the rule's ambiguous wording, and made it harder for investigators to identify eligible study participants by reviewing their medical records. The red tape created by the rule was particularly detrimental to studies involving stored tissues and linkurl:genetic datasets.;http://www.the-scientist.com/news/display/53554/ Because HIPAA makes it more difficult to track patients after a study is completed, investigators may be unable to find and inform study participants of treatments for genetic linkurl:mutations;http://www.the-scientist.com/news/display/38329/ that made them eligible for past studies. Additionally, community health providers and other community researchers might be shying away from participating in broad-scale clinical studies because of potential liability issues raised by HIPAA, the report states. The AAHC recommends that the US Department of Health and Human Services revise HIPAA in a way that continues to protect the privacy of clinical research participants while making studies easier to conduct. The organization also calls on Congress to enact a national genetic privacy act that will not limit access to genetic datasets or tissue banks in the way that HIPAA now does.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo